Sign inJoin waitlistJoin the waitlist

Joshua Reuss

Physician · MedStar Health

Credentials: · · · · · ·

History

MedStar Health
2025–Present

Medical Oncology
2017–2019
Internal Medicine
University of Virginia Medical Center
2014–2017
Doctor of Medicine
2010–2014

Research

Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Nature · 2021 · 464 citations
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer
Nature Cancer · 2020 · 168 citations
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Journal for ImmunoTherapy of Cancer · 2020 · First of 32 authors · 147 citations

JN
Jarushka Naidoo
15 papers
Stephen Liu
15 papers
PF
Patrick Forde
14 papers
Julie Brahmer
12 papers
Chul Kim
11 papers
Kristen Marrone
10 papers
JC
Jamie Chaft
8 papers
Valsamo Anagnostou
8 papers
Janis Taube
7 papers
Shirish Gadgeel
7 papers
Balazs Halmos
6 papers
Dwight Owen
6 papers

Clinical trials

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
Principal investigator · Recruiting · Phase 2
Georgetown University
2026–2032
Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC
Principal investigator · Active not recruiting · Phase 2
Georgetown University
2021–2027
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027